Citizen science reveals landscape-scale exposures to multiazole-resistant <i>Aspergillus fumigatus</i> bioaerosols.

Abstract

Using a citizen science approach, we identify a country-wide exposure to aerosolized spores of a human fungal pathogen, <i>Aspergillus fumigatus</i>, that has acquired resistance to the agricultural fungicide tebuconazole and first-line azole clinical antifungal drugs. Genomic analysis shows no distinction between resistant genotypes found in the environment and in patients, indicating that at least 40% of azole-resistant <i>A. fumigatus</i> infections are acquired from environmental exposures. Hotspots and coldspots of aerosolized azole-resistant spores were not stable between seasonal sampling periods. This suggests a high degree of atmospheric mixing resulting in an estimated per capita cumulative annual exposure of 21 days (±2.6). Because of the ubiquity of this measured exposure, it is imperative that we determine sources of azole-resistant <i>A. fumigatus</i> to reduce treatment failure in patients with aspergillosis.